Reuters logo
BRIEF-Oncolys BioPharma says first patient enrolled into Telomelysin Phase I clinical trial
July 7, 2017 / 8:23 AM / 4 months ago

BRIEF-Oncolys BioPharma says first patient enrolled into Telomelysin Phase I clinical trial

July 7 (Reuters) - Oncolys BioPharma Inc

* Says first patient enrolled into Telomelysin Phase I clinical trial for esophageal cancer treatment

Source text in Japanese:goo.gl/bLnYm8

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below